On January 31st, according to the Lao Times, Laos approved the production of marijuana for regulated medical purposes. Recently, the Ministry of Health of Laos issued an important decision on approving the production and sale of cannabis for medical purposes in Laos.

The decision stipulates that cannabis seeds must be registered and appropriately authorized for their origin.
The Ministry of Health of Laos allows certified enterprises to use cannabis bisphenol (CBD) for medicinal purposes, with the dosage of tetrahydrocannabinol (THC) not exceeding 1% of the drug weight or 0.2% of the raw materials and processed products. Certified enterprises must also construct facilities in accordance with special guidelines to ensure product quality.
According to this decision, health products with cannabinoid (CBD) as the main ingredient and tetrahydrocannabinol content less than 0.2% by weight of the product can be allowed for sale, as long as they indicate it on the product label. At the same time, it is also allowed to sell, distribute, and generally use cosmetics, beverages, and aromatic oils registered with the Food and Drug Department under the Ministry of Health of Laos, with cannabis bisphenol (CBD) as the main ingredient.
Before this decision was approved, Laos also established a working group committee to study the medicinal potential of cannabis.